Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms? Cover

.blurhash-client-img { display: none !important; }

Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?

Archives of Industrial Hygiene and Toxicology

Volume 75 (2024): Issue 1 (March 2024)

By: Aylin Elkama, Nazlıcan İlik, Mehmet Ak and Bensu Karahalil

Open Access

|Mar 2024

Authors

Aylin Elkama

Gazi University Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey

Nazlıcan İlik

Gazi University Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey

Mehmet Ak

Necmettin Erbakan University, Meram Faculty of Medicine, Department of Psychiatry, Konya, Turkey

Bensu Karahalil

bensuka@gmail.com

Gazi University Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey

Eastern Mediterranean University Faculty of Pharmacy, Department of Toxicology, Famagusta, North Cyprus

DOI: https://doi.org/10.2478/aiht-2024-75-3770 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254

Journal RSS Feed

Language: English, Croatian, Slovenian

Page range: 61 - 67

Submitted on: Aug 1, 2023

|

Accepted on: Feb 1, 2024

|

Published on: Mar 29, 2024

Published by: Institute for Medical Research and Occupational Health

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

drug-induced liver injury,

mental disorders,

psychotropic drugs

Related subjects:

Basic medical science,

Basic medical science, other

© 2024 Aylin Elkama, Nazlıcan İlik, Mehmet Ak, Bensu Karahalil, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 75 (2024): Issue 1 (March 2024)Next article